ObGyn Intelligence — Women's Health

PCOS Screener

Rotterdam criteria-based assessment for polycystic ovary syndrome. Covers all four diagnostic phenotypes with exclusion of mimicking conditions.

Evidence Base

  1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. — Defines the Rotterdam diagnostic criteria used in this tool.
  2. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602–1618. — International guideline for PCOS diagnosis and management.
  3. American College of Obstetricians and Gynecologists. Polycystic Ovary Syndrome. ACOG Practice Bulletin No. 194. Obstet Gynecol. 2018;131(6):e157–e171. — ACOG recommendations for clinical assessment and exclusion of mimicking conditions.
  4. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. — AES criteria requiring hyperandrogenism as a mandatory feature.
Intro
Cycles
Androgens
Ultrasound
Exclusions
Result

How This Tool Works

PCOS is diagnosed using the Rotterdam criteria (2004): at least 2 of the following 3 features must be present, after excluding other causes.

CriterionWhat It Means
1. Oligo/AnovulationIrregular or absent periods — cycles >35 days or fewer than 8 cycles per year
2. HyperandrogenismClinical (hirsutism, acne, alopecia) or biochemical (elevated testosterone or DHEAS)
3. Polycystic ovarian morphology≥20 follicles in either ovary on ultrasound, or ovarian volume >10 mL (updated 2018 threshold)
Note: This tool screens for PCOS based on reported symptoms and available test results. A formal diagnosis requires clinical evaluation, examination, and laboratory testing by a qualified clinician.